Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mesa Laboratories (MLAB) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Mesa Laboratories (MLAB) over the last 16 years, with Q4 2025 value amounting to 12.25%.

  • Mesa Laboratories' EBIT Margin rose 30500.0% to 12.25% in Q4 2025 from the same period last year, while for Dec 2025 it was 6.96%, marking a year-over-year increase of 1148100.0%. This contributed to the annual value of 6.78% for FY2025, which is 1326300.0% up from last year.
  • Mesa Laboratories' EBIT Margin amounted to 12.25% in Q4 2025, which was up 30500.0% from 7.78% recorded in Q3 2025.
  • In the past 5 years, Mesa Laboratories' EBIT Margin ranged from a high of 12.25% in Q4 2025 and a low of 460.55% during Q1 2024
  • In the last 5 years, Mesa Laboratories' EBIT Margin had a median value of 5.61% in 2024 and averaged 18.88%.
  • Per our database at Business Quant, Mesa Laboratories' EBIT Margin plummeted by -4614800bps in 2024 and then skyrocketed by 4629200bps in 2025.
  • Quarter analysis of 5 years shows Mesa Laboratories' EBIT Margin stood at 4.59% in 2021, then skyrocketed by 236bps to 6.27% in 2022, then plummeted by -102bps to 0.13% in 2023, then skyrocketed by 7440bps to 9.2% in 2024, then surged by 33bps to 12.25% in 2025.
  • Its last three reported values are 12.25% in Q4 2025, 7.78% for Q3 2025, and 5.15% during Q2 2025.